de Pablos-Velasco Pedro, Martínez-Martín Francisco Javier, Rodríguez Pérez Fátima, Urioste Luis Miguel, García Robles Rafael
Endocrinology Department, Hospital General de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain.
J Hypertens. 2002 Oct;20(10):1965-71. doi: 10.1097/00004872-200210000-00015.
To estimate the prevalence, awareness, treatment and control of hypertension in a Canarian population; and their relationship with the glucose tolerance categories.
From a population of 6355 subjects over 29 years old, 690 were chosen in a random sampling. Blood pressure measurements, a standard oral glucose tolerance test (excluding known diabetic patients), and a questionnaire on diabetes and hypertension history and medication use was performed.
The total prevalence of hypertension was 50.3%; 62.0% of the hypertensive subjects were aware of their condition; 60.6% had their diastolic and 11.0% their systolic blood pressure controlled and 8.6% had both. For diabetic, glucose intolerant and normoglycemic subjects, the respective prevalences of hypertension were 79.4, 60.2 and 43.1% (higher in diabetic subjects, P < 0.001); the awareness of hypertension was 66.7, 61.8 and 59.5% (differences not significant); systolic blood pressure control was 4.8, 14.7 and 13.7% (lower in diabetic subjects, P = 0.017 versus glucose intolerant and P = 0.011 versus normoglycemic subjects); diastolic blood pressure control was 50.4, 72.1 and 63.2% (lower in diabetic subjects, P = 0.004 versus glucose intolerant and P = 0.025 versus normoglycemic subjects). There were no differences in the number and type of antihypertensive drugs among the different glucose tolerance categories.
Blood pressure was comparable in our population and in other European populations. The prevalence of hypertension was higher, the awareness was similar, and control was worse in diabetic than in non-diabetic subjects; the drug treatment pattern was not different.
评估加那利群岛人群中高血压的患病率、知晓率、治疗率及控制率;并研究其与葡萄糖耐量类别之间的关系。
从6355名29岁以上的人群中随机抽取690人。进行血压测量、标准口服葡萄糖耐量试验(不包括已知糖尿病患者),并开展关于糖尿病和高血压病史及用药情况的问卷调查。
高血压的总患病率为50.3%;62.0%的高血压患者知晓自己的病情;60.6%的患者舒张压得到控制,11.0%的患者收缩压得到控制,8.6%的患者两者均得到控制。糖尿病患者、葡萄糖不耐受者和血糖正常者的高血压患病率分别为79.4%、60.2%和43.1%(糖尿病患者中更高,P<0.001);高血压知晓率分别为66.7%、61.8%和59.5%(差异不显著);收缩压控制率分别为4.8%、14.7%和13.7%(糖尿病患者低于葡萄糖不耐受者,P=0.017;低于血糖正常者,P=0.011);舒张压控制率分别为50.4%、72.1%和63.2%(糖尿病患者低于葡萄糖不耐受者,P=0.004;低于血糖正常者,P=0.025)。不同葡萄糖耐量类别之间抗高血压药物的数量和类型没有差异。
我们人群中的血压情况与其他欧洲人群相当。糖尿病患者的高血压患病率更高,知晓率相似,但控制情况比非糖尿病患者更差;药物治疗模式没有差异。